SORT BY

FILTER BY

fastest growing stats

also on other fortune lists

100 Fastest-Growing Companies

Doug Abdelnour

50

Regeneron Pharmaceuticals

REGN

With four FDA-approved drugs, this biotech firm based in Tarrytown, N.Y., has seen its share price surge as much as 40% this year.

Looking for leads, investment insights, or competitive intelligence?

Location

Tarrytown, N.Y.

Industry

Pharmaceuticals

Sector

Health Care

Current Streak

-

Years on List

1

CEO

Leonard Schleifer

Revenue and net income for the four quarters ended on or before April 30, 2017. Total return for the period ended June 30, 2017.
Revenue, Net Income
$ millions
Revenue past four quarters ($M)$4,9794,979%
Net Income past four quarters ($M)$963963%
Growth Rates and Ranks
Revenue 3 Yr Growth Rank45
Revenue 3 Yr Annual Growth Rate33%
EPS 3 Yr Growth Rank51
EPS 3 Yr Annual Growth Rate38%
Total Return 3 Yr Rank61
Total Return 3 Yr Annual Rate20%
Beat S&P 500 (9.6%)Yes
P/E Ratio45
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Regeneron Pharmaceuticals

The Diseases We Aren't Curing—And Why

Drug makers are flocking to certain treatment types. Why do others get left behind?

Read More →
Could a Vaccine Prevent High Cholesterol and Heart Disease?

Scientists are ready to move an experimental treatment into phase 1 trials.

Read More →
Trump's Proposed Science Cuts Could Devastate Future Generations, Pharma Expert Says

“We should only be working on two things, health and the freaking environment.”

Read More →
Pharma Executives Aren't Excited About Trump's Plans to Ease FDA Regulation

They say a robust review process is needed to convince doctors and insurers new drugs have value.

Read More →